NY-ESO-1 protein cancer vaccine with TLR 3 and 4 agonists

被引：0
|
作者：
Takeoka, Tomohira [1 ]
Nagase, Hirotsugu [1 ]
Miyazaki, Yasuhiro [1 ]
Takahashi, Tsuyoshi [1 ]
Kurokawa, Yukinori [1 ]
Makino, Tomoki [1 ]
Yamasaki, Makoto [1 ]
Takiguchi, Shuji [1 ]
Mori, Masaki [1 ]
Doki, Yuichiro [1 ]
Wada, Hisashi [2 ]
机构：
[1] Osaka Univ, Dept Gastroenterol Surg, Suita, Osaka, Japan
[2] Osaka Univ, Dept Clin Res Tumor Immunol, Suita, Osaka, Japan
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR15-A169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A169
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant effect of TLR-3 agonist, Poly-ICLC, on NY-ESO-1 Protein Cancer Vaccine
    Urakawa, Shinya
    Wada, Hisashi
    Takeoka, Tomohira
    Kato, Ryo
    Nishida, Kentaro
    Tanaka, Koji
    Miyazaki, Yasuhiro
    Makino, Tomoki
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Mori, Masaki
    Doki, Yuichiro
    CANCER SCIENCE, 2018, 109 : 278 - 278
  • [2] Evaluation of persisting NY-ESO-1 immunity in patients who have previously been vaccinated with NY-ESO-1 ISCOMATIRX® or NY-ESO-1 protein alone
    Nicholaou, T
    Chen, W
    Davis, ID
    Jackson, H
    Dimopoulos, N
    Barrow, C
    Hopkins, W
    Maraskovsky, E
    Hoffman, E
    Old, LJ
    Cebon, J
    TISSUE ANTIGENS, 2005, 66 (05): : 503 - 503
  • [3] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
    Chen, Ji-Li
    Dawoodji, Amina
    Tarlton, Andrea
    Gnjatic, Sacha
    Tajar, Abdelouahid
    Karydis, Ioannis
    Browning, Judy
    Pratap, Sarah
    Verfaille, Christian
    Venhaus, Ralph R.
    Pan, Linda
    Altman, Douglas G.
    Cebon, Jonathan S.
    Old, Lloyd L.
    Nathan, Paul
    Ottensmeier, Christian
    Middleton, Mark
    Cerundolo, Vincenzo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E590 - E601
  • [4] Saccharomyces cerevisiae as delivery vehicle for a NY-ESO-1 protein vaccine.
    Renner, C.
    Held, G.
    Neumann, F.
    Kleber, S.
    Thiel, M.
    Karbach, J.
    Jäger, E.
    Strahl, S.
    Wadle, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 119S - 119S
  • [5] Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
    Odunsi, Kunle
    Matsuzaki, Junko
    James, Smitha R.
    Mhawech-Fauceglia, Paulette
    Tsuji, Takemasa
    Miller, Austin
    Zhang, Wa
    Akers, Stacey N.
    Griffiths, Elizabeth A.
    Miliotto, Anthony
    Beck, Amy
    Batt, Carl A.
    Ritter, Gerd
    Lele, Shashikant
    Gnjatic, Sacha
    Karpf, Adam R.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (01) : 37 - 49
  • [6] Toward the Total Chemical Synthesis of the Cancer Protein NY-ESO-1
    Harris, Paul W. R.
    Brimble, Margaret A.
    BIOPOLYMERS, 2010, 94 (04) : 542 - 550
  • [7] Ludwig Institute and Cornell collaborate on NY-ESO-1 vaccine
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (10) : 1418 - 1418
  • [8] Public NY-ESO-1 specific TCRs as novel biomarkers for immune monitoring of NY-ESO-1 positive cancer patients
    Lu, Hailing
    Pollack, Seth
    Somaiah, Neeta
    Chawla, Sant
    Hwu, Patrick
    Vignali, Marissa
    Rytlewski, Julie
    Gnjatic, Sacha
    ter Meulen, Jan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [9] Expression and immunogenicity of NY-ESO-1 in colorectal cancer
    Li, Ya
    Song, Ruifeng
    Li, Xinqiang
    Xu, Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3581 - 3585
  • [10] NY-ESO-1 and clinicopathological features in ovarian cancer
    Topka, Charlotte R.
    ElMasri, Wafic M.
    Magyar, Clara E.
    Song, Min
    Dorigo, Oliver
    CANCER RESEARCH, 2012, 72
12345